Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating novel candidate regulators of metastasis and disease progression in a zebrafish model of metastatic rhabdomyosarcoma
EF 2023-24
Résumé
Rhabdomyosarcoma, or RMS, is the most prevalent form of pediatric soft-tissue sarcoma, with more than a 70% fatality rate for patients where tumor cells have spread and form distant metastases. Understanding the reasons for RMS progression and metastasis is crucial for the discovery of novel therapeutics to better treat this aggressive disease. The current project aims to address gaps in our knowledge related to RMS progression and metastasis by defining specific cell types associated with metastatic RMS, as well as testing roles for potentially causative genetic signaling pathways. My investigations will focus on a zebrafish model of metastatic RMS, which is highly similar to human with respect to gene expression and tumor cell behaviour. This, along with the optical transparency and amenability of zebrafish for high-throughput screening approaches, makes zebrafish an ideal model to closely investigate biology related to metastatic RMS. I aim to directly visualize tumor cells and associated tissues in live zebrafish RMS, as well as manipulate signaling pathways to test the role for specific factors associated with metastatic progression. By furthering our understanding of specific mechanisms underlying the severity and spread of RMS using zebrafish modeling, we hope to identify novel therapeutic opportunities for patients. Findings from this project will inform future pre-clinical studies of candidate therapeutics, with the goal of translating effective drugs and/or drug combinations to the clinic. Altogether, this project has the potential to inform future RMS treatments and improve patient outcomes, and would therefore have a broader clinical significance for children diagnosed with aggressive pediatric disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506341
Name
Venditti Veronica
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating novel candidate regulators of metastasis and disease progression in a zebrafish model of metastatic rhabdomyosarcoma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cancer Modelling; Disease Modelling; Genetic Pathways; Metastasis; Novel Therapeutics; Oncogenes; Rhabdomyosarcoma; Tumor Microenvironment; Zebrafish
Abstract
Rhabdomyosarcoma, or RMS, is the most prevalent form of pediatric soft-tissue sarcoma, with more than a 70% fatality rate for patients where tumor cells have spread and form distant metastases. Understanding the reasons for RMS progression and metastasis is crucial for the discovery of novel therapeutics to better treat this aggressive disease. The current project aims to address gaps in our knowledge related to RMS progression and metastasis by defining specific cell types associated with metastatic RMS, as well as testing roles for potentially causative genetic signaling pathways. My investigations will focus on a zebrafish model of metastatic RMS, which is highly similar to human with respect to gene expression and tumor cell behaviour. This, along with the optical transparency and amenability of zebrafish for high-throughput screening approaches, makes zebrafish an ideal model to closely investigate biology related to metastatic RMS. I aim to directly visualize tumor cells and associated tissues in live zebrafish RMS, as well as manipulate signaling pathways to test the role for specific factors associated with metastatic progression. By furthering our understanding of specific mechanisms underlying the severity and spread of RMS using zebrafish modeling, we hope to identify novel therapeutic opportunities for patients. Findings from this project will inform future pre-clinical studies of candidate therapeutics, with the goal of translating effective drugs and/or drug combinations to the clinic. Altogether, this project has the potential to inform future RMS treatments and improve patient outcomes, and would therefore have a broader clinical significance for children diagnosed with aggressive pediatric disease.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Venditti, Veronica
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~